Eicosapentaenoic acid and docosahexaenoic acid have distinct membrane locations and lipid interactions as determined by X-ray diffraction
Open accessAbstract
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) differentially influence lipid oxidation, signal transduction, fluidity, and cholesterol domain formation, potentially due in part to distinct membrane interactions. We used small angle X-ray diffraction to evaluate the EPA and DHA effects on membrane structure. Membrane vesicles composed of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and cholesterol (C) (0.3C:POPC mole ratio) were prepared and treated with vehicle, EPA, or DHA (1:10 mol ratio to POPC). Electron density profiles generated from the diffraction data showed that EPA increased membrane hydrocarbon core electron density over a broad area, up to ± 20 Å from the membrane center, indicating an energetically favorable extended orientation for EPA likely stabilized by van der Waals interactions. By contrast, DHA increased electron density in the phospholipid head group region starting at ± 12 Å from the membrane center, presumably due to DHA-surface interactions, with coincident reduction in electron density in the membrane hydrocarbon core centered ± 7-9 Å from the membrane center. The membrane width (d-space) decreased by 5 Å in the presence of vehicle as the temperature increased from 10 °C to 30 °C due to increased acyl chain trans-gauche isomerizations, which was unaffected by addition of EPA or DHA. The influence of DHA on membrane structure was modulated by temperature changes while the interactions of EPA were unaffected. The contrasting EPA and DHA effects on membrane structure indicate distinct molecular locations and orientations that may contribute to observed differences in biological activity.
AI snapshot
Written from the paper’s full text.
TL;DR
Small-angle X-ray diffraction of POPC/cholesterol model membranes shows that EPA and DHA have distinct membrane locations and lipid interactions. EPA increases hydrocarbon-core electron density, whereas DHA increases headgroup-region electron density with a coincident reduction in the hydrocarbon core.
Key findings
- EPA increased membrane hydrocarbon-core electron density over a broad area: ±15 Å from the membrane center at 20 °C and 30 °C, and ±20 Å at 10 °C; these changes were consistent across all temperatures tested.
- DHA increased electron density starting at ±12 Å from the membrane center and extending to the surface, with a coincident reduction in hydrocarbon-core electron density centered at ±7–9 Å from the center. DHA effects were more temperature-dependent, decreasing at higher temperature.
- Membrane d-space decreased by 5 Å in vehicle-treated membranes as temperature increased from 10 °C to 30 °C, from 59 Å to 55 Å, due to increased acyl-chain trans-gauche isomerizations; this was unaffected by EPA or DHA. Table 1 reports control d-space (intrabilayer width) values of 59 (44) Å at 10 °C, 57 (42) Å at 20 °C, and 55 (41) Å at 30 °C; EPA values were 60 (44), 56 (42), and 55 (41) Å; DHA values were 59 (44), 56 (42), and 54 (41) Å.
- The authors propose EPA adopts an extended orientation in the hydrocarbon core parallel to surrounding acyl chains, while DHA interacts more with the phospholipid headgroup region, likely due to rapid conformational changes.
Methods
- Model membranes were composed of POPC and cholesterol at a 0.3:1 cholesterol-to-phospholipid mole ratio and treated with vehicle, EPA, or DHA at a 1:10 omega-3 fatty acid-to-phospholipid mole ratio. Multilamellar vesicles were prepared in diffraction buffer (0.5 mM HEPES, 154 mM NaCl, pH 7.3) at 2.5 mg/mL phospholipid, oriented by centrifugation, and incubated at 74% relative humidity.
- Small-angle X-ray diffraction was performed at 10 °C, 20 °C, and 30 °C using a CuKα X-ray beam and a one-dimensional position-sensitive detector located 150 mm from the sample. Membrane d-space was calculated by Bragg’s Law, and Fourier transformation generated time-averaged electron density profiles; phasing used a hydration/swelling analysis, with crystalline cholesterol monohydrate for detector calibration.
Limitations
- The paper states that these experiments were conducted using a model membrane study, and further study is needed to elucidate how these distinct lipid interactions influence function in biological membranes from different tissues.
- The paper states that POPC lipids with relatively short fatty acid chain lengths were used, and membranes containing longer acyl chains may produce differential effects on the location of EPA and DHA.
- Evident from the text: only one lipid composition and cholesterol ratio, three temperatures, and relatively low PUFA concentrations (<3% by mass) were tested; no direct biological or functional outcomes were measured. The paper also notes that EPA conformational changes have not been well studied.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 41 cited sources checked · 0 supported · 0 flagged
- Findingown data
In the presence of EPA, the increase in hydrocarbon core electron density extended to ±15 Å from the membrane center at 20 °C and 30 °C.
“In the presence of EPA, the electron density associated with the membrane hydrocarbon core increased ± 15 Å from the center of the membrane at both 20° and 30° C, respectively.”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Findingown data
DHA caused a coincident reduction in electron density in the membrane hydrocarbon core centered at ±7-9 Å from the membrane center.
“with coincident reduction in electron density in the membrane hydrocarbon core centered ± 7-9 Å from the membrane center”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Findingown data
DHA increased electron density in the phospholipid head group region starting at ±12 Å from the membrane center.
“DHA increased electron density in the phospholipid head group region starting at ± 12 Å from the membrane center”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Findingown data
The temperature-induced decrease in membrane width was unaffected by addition of EPA or DHA.
“which was unaffected by addition of EPA or DHA”
Quote in the paperNot a substantial claim- Rests on an assumption: The temperature-induced decrease in membrane width is due to increased acyl chain trans-gauche isomerizations.
- Findingreasoning
Membrane width (d-space) decreased by 5 Å in vehicle-treated membranes as temperature increased from 10 °C to 30 °C.
“The membrane width (d-space) decreased by 5 Å in the presence of vehicle as the temperature increased from 10 °C to 30 °C”
Quote in the paperNot a substantial claim- Rests on an assumption: The temperature-induced decrease in membrane width is due to increased acyl chain trans-gauche isomerizations.
- Findingown data
EPA increased membrane hydrocarbon core electron density over a broad area, up to ±20 Å from the membrane center.
“EPA increased membrane hydrocarbon core electron density over a broad area, up to ± 20 Å from the membrane center”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Findingown data
The changes in electron density in the hydrocarbon core were consistent at all temperatures tested.
“The changes in electron density in the hydrocarbon core were consistent at all temperatures tested (Fig. 3A-C).”
Quote in the paperNot a substantial claim - Findingown data
We observed pronounced differences in membrane structure following addition of EPA and DHA under identical conditions.
“We observed pronounced differences in membrane structure following addition of EPA and DHA under identical conditions.”
Quote in the paperSubstantial claim - Findingown data
DHA effects displayed stronger temperature-dependence as evidenced by a decrease in the extent of electron density changes at higher temperature.
“DHA effects displayed stronger temperature-dependence as evidenced by a decrease in the extent of electron density changes at higher temperature.”
Quote in the paperSubstantial claim - Study design and conductown data
The center of mass position of the headgroups was not influenced by the presence of the PUFAs at concentrations <3% by mass over the range of temperatures.
“The center of mass position of the headgroups were not influenced by the presence of the PUFAs at these relatively low concentrations (< 3% by mass) over a range of temperatures.”
Quote in the paperNot a substantial claim - Premisecitation
As a result of differences in fatty acid length and number of double bonds, DHA has a greater effect on cholesterol-poor membrane fluidity relative to EPA.
“As a result of differences in fatty acid length and the number of double bonds, DHA also has a greater effect on cholesterolpoor membrane fluidity relative to EPA (Hashimoto et al., 1999;Mason et al., 2016a).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Hashimoto et al., 1999 source
Not checked in the free run.
- cites Mason et al., 2016a
Not checked in the free run.
- Interpretationreasoning
Rapid conformational changes may reduce DHA interactions with cholesterol molecules.
“Such rapid conformational changes may reduce DHA interactions with cholesterol molecules, which have a rigid steroid ring structure with a long axis parallel to surrounding phospholipid acyl chains (Soni et al., 2008;Wassall and Stillwell, 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Soni et al., 2008 source
Not checked in the free run.
- cites Wassall and Stillwell, 2008
Not checked in the free run.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
- Interpretationown data
DHA interacts with the membrane surface/headgroup region, presumably due to DHA-surface interactions.
“DHA increased electron density in the phospholipid head group region starting at ± 12 Å from the membrane center, presumably due to DHA-surface interactions”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Interpretationown data
EPA adopts an average membrane orientation with its long axis parallel to the surrounding acyl chains.
“EPA increased membrane hydrocarbon core electron density over a broad area, indicating an average membrane orientation for EPA with its long axis parallel to the surrounding acyl chains.”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
- Premisecitation
EPA has demonstrated inhibition of cholesterol domain formation in membranes exposed to oxidative stress as compared to other triglyceride-lowering agents.
“EPA has demonstrated inhibition of cholesterol domain formation in membranes exposed to oxidative stress as compared to other triglyceride (TG)-lowering agents (Mason and Jacob, 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mason and Jacob, 2015
Not checked in the free run.
- Interpretationreasoning
The DHA effects were influenced by temperature, likely due to changes in the rotational dynamics of the surrounding membrane lipids.
“The DHA effects were influenced by temperature, likely due to changes in the rotational dynamics of the surrounding membrane lipids.”
Quote in the paperNot a substantial claim- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
- Premisecitation
DHA has been shown to undergo rapid conformational changes within membranes.
“DHA has been shown to undergo rapid conformational changes within membranes, and therefore by contrast, DHA may interact with a different part of the membrane bilayer than EPA, perhaps due to its additional carbon length and double bond, resulting in rapid conformation changes that lead to promotion of cholesterol domain formation, increased lipid disorder, and a limitation in its antioxidant capa”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Due to its longer chain length, DHA has different effects than EPA on membrane fluidity, cholesterol organization, and rates of membrane and lipoprotein oxidation.
“Due to its longer chain length, DHA has different effects than EPA on membrane fluidity, cholesterol organization, and rates of membrane and lipoprotein oxidation (Mason and Jacob, 2015;Mason et al., 2016a,b Shaikh, 2012;Shaikh et al., 2015;Williams et al., 2012).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites Mason and Jacob, 2015
Not checked in the free run.
- cites Mason et al., 2016a,b
Not checked in the free run.
- cites Shaikh, 2012 source
Not checked in the free run.
- Premisecitation
In previous work, EPA differed from DHA in antioxidant and membrane structure effects.
“In previous work we found that EPA differed from DHA in antioxidant and membrane structure effects (Mason and Jacob, 2015;Mason et al., 2016a,b).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Mason and Jacob, 2015
Not checked in the free run.
- cites Mason et al., 2016a,b
Not checked in the free run.
- Premisecitation
In the JELIS trial, purified EPA reduced the rate of CAD events in a manner not predicted by changes in lipid levels alone.
“in a large clinical trial (JELIS), purified EPA reduced the rate of CAD events in a manner that was not predicted by changes in lipid levels alone (Yokoyama et al., 2007).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Yokoyama et al., 2007 source
Not checked in the free run.
- Premisecitation
EPA treatment led to coronary plaque regression in a smaller study of statin-treated patients with coronary disease (CHERRY study).
“EPA treatment also led to coronary plaque regression in a smaller study of statin-treated patients with coronary disease as observed in the Combination Therapy of Eicosapentaenoic Acid and Pitavastatin for Coronary Plaque Regression Evaluated by Integrated Backscatter Intravascular Ultrasonography (CHERRY) study (Watanabe et al., 2017).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Watanabe et al., 2017 source
Not checked in the free run.
- Interpretationreasoning
The unique location of EPA within cell or lipoprotein membranes, where conjugated double bonds lie along the parallel axis of surrounding phospholipids, may be an ideal location for preventing propagation of free radicals through the membrane.
“This may be attributed to the unique location of EPA within cell or lipoprotein membranes, where the conjugated double bonds appear to lie along the parallel axis of surrounding phospholipids, a potentially ideal location for preventing the propagation of free radicals through the membrane.”
Quote in the paperSubstantial claim- Rests on an assumption: Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations influenced by their biological environment.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
- Premisereasoning
Changes in electron density distribution in the presence of omega-3 fatty acids versus vehicle allow determination of structural effects on the membrane bilayer.
“Changes in electron density distribution that occur in the presence of the omega-3 fatty acids (versus vehicle) allow for the determination of structural effects on the membrane bilayer.”
Quote in the paperSubstantial claim - Interpretationreasoning
The unique location of EPA in the membrane may explain certain clinical benefits.
“The unique location of EPA in the membrane may explain certain clinical benefits.”
Quote in the paperSubstantial claim - Premisecitation
EPA has been shown to decrease oxidation of lipids within lipoproteins in a more prolonged manner compared to DHA.
“Similarly, EPA has been shown to decrease oxidation of lipids within lipoproteins in a more prolonged manner compared to DHA (Mason et al., 2016b).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Mason et al., 2016b
Not checked in the free run.
- May combine two claims. 14
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 16
May combine two claims.
Findingown dataThe influence of DHA on membrane structure was modulated by temperature changes, while the interactions of EPA were unaffected by temperature.
“The influence of DHA on membrane structure was modulated by temperature changes while the interactions of EPA were unaffected.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataAt 10 °C, the EPA-induced increase in hydrocarbon core electron density extended to ±20 Å from the membrane center.
“At 10° C, the electron density associated with the membrane hydrocarbon core was ± 20 Å from the center of the membrane”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
Probably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataIn all samples, we observed a large first order and smaller subsequent orders (maximum of four orders).
“In all the samples, we observed a large first order and smaller subsequent orders (maximum of four orders).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataEPA allows cholesterol to remain evenly distributed within the membrane, a property essential for neuronal cell function, while DHA promotes formation of cholesterol-rich microdomains.
“These findings suggest that EPA allows cholesterol to remain evenly distributed within the membrane, a property that is essential for neuronal cell function (Brzustowicz et al., 2002), while DHA promotes the formation of cholesterol-rich microdomains (Mason et al., 2016a).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Brzustowicz et al., 2002 source
Not checked in the free run.
- cites Mason et al., 2016a
Not checked in the free run.
May combine two claims.
PremisecitationEPA did not alter fluidity in membranes enriched with cholesterol and maintained cholesterol in its fluid (non-domain) state.
“In contrast, EPA did not alter fluidity in membranes enriched with cholesterol and maintained cholesterol in its fluid (non-domain) state.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mason et al., 2016a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationChanges in membrane cholesterol content influence the conformation and packing constraints of adjacent phospholipid acyl chains, leading to increased membrane width.
“changes in membrane cholesterol content influence the conformation and packing constraints of adjacent phospholipid acyl chains, leading to increased membrane width (Tulenko et al., 1998).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Tulenko et al., 1998 source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThe distinct interactions of DHA are likely due to rapid conformational changes associated with its chemical structure, compared to EPA which appears to have a more stable extended structure in the phospholipid bilayer.
“The distinct interactions of DHA as measured in this study are likely due to rapid conformational changes associated with its chemical structure as compared to EPA which appears to have a more stable extended structure in the phospholipid bilayer environment.”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations influenced by their biological environment.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
- Rests on an assumption: EPA conformational changes have not been well studied.
May combine two claims.
InterpretationreasoningThe contrasting EPA and DHA effects on membrane structure indicate distinct molecular locations and orientations that may contribute to observed differences in biological activity.
“The contrasting EPA and DHA effects on membrane structure indicate distinct molecular locations and orientations that may contribute to observed differences in biological activity.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataEPA and DHA interact with distinct regions of the membrane lipid bilayer: EPA associated with the hydrocarbon core while DHA interacted with the headgroup region.
“EPA and DHA interact with distinct regions of the membrane lipid bilayer.EPA was associated with the hydrocarbon core while DHA interacted with the headgroup region.”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
May combine two claims.
InterpretationcitationThe more rapid conformational changes for DHA may contribute to formation of cholesterol microdomains and to its preferential association with cholesterol-poor regions of the membrane, as compared to a more even lipid distribution with EPA.
“Thus, the more rapid conformational changes for DHA may contribute to formation of cholesterol microdomains and to its preferential association with cholesterol poor regions of the membrane, as compared to an apparently more even lipid distribution with EPA (Soni et al., 2008;Wassall and Stillwell, 2008).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites Soni et al., 2008 source
Not checked in the free run.
- cites Wassall and Stillwell, 2008
Not checked in the free run.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationCholesterol molecules have a rigid steroid ring structure with a long axis parallel to surrounding phospholipid acyl chains.
“Such rapid conformational changes may reduce DHA interactions with cholesterol molecules, which have a rigid steroid ring structure with a long axis parallel to surrounding phospholipid acyl chains (Soni et al., 2008;Wassall and Stillwell, 2008).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Soni et al., 2008 source
Not checked in the free run.
- cites Wassall and Stillwell, 2008
Not checked in the free run.
May combine two claims.
PremisecitationDHA-treated membranes increased membrane fluidity in a dose-dependent manner while simultaneously inducing formation of distinct cholesterol microdomains at various temperatures.
“We previously demonstrated that DHA-treated membranes increased membrane fluidity in a dose-dependent manner (Mason et al., 2016a) while simultaneously inducing the formation of distinct cholesterol microdomains at various temperatures.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mason et al., 2016a
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationDHA is able to change conformations quickly (nanosecond time scale) in a membrane environment.
“Previous studies have demonstrated that DHA is able to change conformations quickly (nanosecond time scale) in a membrane environment (Soubias and Gawrisch, 2007)”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Soubias and Gawrisch, 2007
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe presence of four diffraction orders was preserved at all temperatures and treatments.
“The presence of the four diffraction orders was preserved at all temperatures and treatments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn JELIS, purified EPA (1.8 g/day) was effective in preventing coronary artery disease in hypercholesterolemic patients also receiving statin treatment.
“In the Japan EPA Lipid Intervention Study (JELIS), purified EPA (1.8 g/day) was effective in preventing coronary artery disease (CAD) in hypercholesterolemic patients also receiving statin treatment (Yokoyama et al., 2007).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Yokoyama et al., 2007 source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based).
Interpretationnone givenThe distinct interactions of DHA are likely attributed to its rapid conformational changes.
“likely attributed to its rapid conformational changes”
Quote in the paperNot a substantial claim- Rests on an assumption: Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations influenced by their biological environment.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSimilar associations with cholesterol have been observed in membranes enriched with other PUFAs, including important changes in the orientation and location of the sterol molecule as determined by neutron diffraction.
“Similar associations with cholesterol have been observed in membranes enriched with other PUFAs, including important changes in the orientation and location of the sterol molecule as determined by neutron diffraction (Brzustowicz et al., 2002;Kucerka et al., 2010;Kucerka et al., 2009).”
Quote in the paperNot a substantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAvailable clinical evidence indicates that dietary consumption of long-chain omega-3 fatty acids correlates with reduced risk for cardiovascular mortality and morbidity.
“Available clinical evidence indicates that dietary consumption of long-chain, omega-3 fatty acids correlates with reduced risk for cardiovascular mortality and morbidity (Daviglus et al., 1997;Mozaffarian and Wu, 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationEPA has various biological effects, including anti-inflammatory, decreased platelet aggregation, and lipid-lowering actions.
“Eicosapentaenoic acid (EPA; 20:5; n-3) is a long-chain omega-3 polyunsaturated fatty acid (PUFA) that has been shown to have various biological effects, including anti-inflammatory, decreased platelet aggregation, and lipidlowering actions (Borow et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Borow et al., 2015 source
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationFourier transformation of collected X-ray diffraction data provides the time-averaged electron density distribution associated with the membrane lipid bilayer.
“Fourier transformation of the collected X-ray diffraction data provides the time-averaged electron density distribution (distance, Å, versus electrons/Å 3 ) associated with the membrane lipid bilayer, as previously described (Mason et al., 1989).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites Mason et al., 1989 source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA measurement of crystalline cholesterol monohydrate was used to verify the detector calibration.
“A measurement of crystalline cholesterol monohydrate was used to verify the detector calibration.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationOmega-3 fatty acids are integrated into biological membranes including those in atherosclerotic plaque where they influence signal transduction pathways involved in atherogenesis.
“Omega-3 fatty acids are integrated into biological membranes including those in the atherosclerotic plaque where they influence signal transduction pathways involved in atherogenesis (Calder, 2012;Mozaffarian and Wu, 2011).”
Quote in the paperNot a substantial claim0 of 2 sources checkedClassified as probably not a substantial claim.
PremisecitationIntensity data at different relative humidities each with unique unit cell distances are used to assign an unambiguous phase combination to experimentally obtained structure factors.
“Intensity data at different relative humidities each with unique unit cell distances are used to assign an unambiguous phase combination to the experimentally obtained structure factors.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
Interpretationown dataIn the presence of cholesterol, EPA intercalates into the membrane with its long axis parallel to the phospholipid acyl chains, potentially allowing EPA to concentrate in endothelial and other membranes associated with atherosclerotic plaque.
“The current experiments suggest that in the presence of cholesterol EPA intercalates into the membrane with its long axis parallel to the phospholipid acyl chains, potentially allowing EPA to concentrate in endothelial and other membranes associated with atherosclerotic plaque.”
Quote in the paperSubstantial claim- Rests on an assumption: Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations influenced by their biological environment.
- Rests on an assumption: Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDHA influences membrane structure and has essential functions in nervous tissues where it is abundant.
“Docosahexaenoic acid (DHA; 22:6; n-3) is also a long-chain omega-3 fatty PUFA that influences membrane structure and has essential functions in nervous tissues where it is abundant (Innis, 2007;Uauy and Dangour, 2006).”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites Innis, 2007 source
Not checked in the free run.
- cites Uauy and Dangour, 2006
Not checked in the free run.
May combine two claims.
InterpretationreasoningEPA appears to maintain a primarily extended orientation in the hydrocarbon core surrounded by phospholipid acyl chains, while DHA had decreased presence within the hydrocarbon core and more interactions with the phospholipid head group structure.
“EPA appears to maintain a primarily extended orientation in the hydrocarbon core surrounded by phospholipid acyl chains, while DHA had decreased presence within the hydrocarbon core and more interactions with the phospholipid head group structure”
Quote in the paperSubstantial claim- Rests on an assumption: At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
- Rests on an assumption: The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDHA effects have been well studied in neurological-related experiments, while EPA has direct vascular effects characterized in cellular and animal models of atherosclerosis leading to reduced inflammation and endothelial dysfunction, as well as improved plaque stabilization.
“It is interesting that DHA effects have been well studied in neurological-related experiments, while EPA has direct vascular effects that have been well characterized in cellular and animal models of atherosclerosis that lead to reduced inflammation and endothelial dysfunction, as well as improved plaque stabilization (Borow et al., 2015).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites Borow et al., 2015 source
Not checked in the free run.
The paper relies on this without support.
At the levels of PUFAs used, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.
“At the levels of PUFAs used in these experiments, changes in electron density can be attributed to the additive electron density of the PUFAs and simultaneous effects on neighboring lipid molecules.”
The paper relies on this without support.
The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum at the center is associated with terminal methylene segments of the phospholipid acyl chains.
“The two peaks of electron density on either side of the centrosymmetric profile correspond to phospholipid head groups, while the minimum of electron density at the center of the membrane is associated with terminal methylene segments of the phospholipid acyl chains.”
The paper relies on this without support.
The temperature-induced decrease in membrane width is due to increased acyl chain trans-gauche isomerizations.
“With increasing temperature, the vehicle treated membranes had a decrease in width by 5 Å due to increased acyl chain trans-gauche isomerizations, which was unaffected by treatment.”
The paper relies on this without support.
Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations influenced by their biological environment.
“Conformational changes for EPA and DHA are facilitated by multiple double bonds with orientations that are influenced by their biological environment.”
The paper relies on this without support.
Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.
“Following insertion into the membrane, the rotational dynamics of omega-3 fatty acids are modulated by surrounding lipids, including phospholipid and cholesterol molecules.”
The paper relies on this without support.
EPA conformational changes have not been well studied.
“but EPA conformational changes have not been well studied.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
EPA and DHA interact with cellular membranes in different ways.
“EPA and DHA interact differently with cellular membranes”
From Cardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids (2021) · cites this paper as [25]
Cites
Diffusion of univalent ions across the lamellae of swollen phospholipids
Bangham, A. D., Standish, M. M., & Watkins, J. C. (1965) · Journal of Molecular Biology · doi:10.1016/s0022-2836(65)80093-6 · Cited by 4,664 · see citing works
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516 · see citing works
Omega-3 Fatty Acids and Cardiovascular Disease
Mozaffarian, D., & Wu, J. H. Y. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.063 · Cited by 1,771 · see citing works
Dietary (n-3) Fatty Acids and Brain Development1
Innis, S. M. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.4.855 · Cited by 906 · see citing works
Fish consumption and the 30-year risk of fatal myocardial infarction
Daviglus, M. L., Stamler, J., Orencia, A. J., Dyer, A. R., Liu, K., Greenland, P., Walsh, M. K., Morris, D., & Shekelle, R. B. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361502 · Cited by 902 · see citing works
Nutrition in Brain Development and Aging: Role of Essential Fatty Acids
Uauy, R. D., & Dangour, A. D. (2006) · Nutrition Reviews · doi:10.1301/nr.2006.may.s24-s33 · Cited by 417 · see citing works
Calder, P. C. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100710 · Cited by 255 · see citing works
Docosahexaenoic acid domains: the ultimate non-raft membrane domain
Wassall, S. R., & Stillwell, W. H. (2008) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2008.02.010 · Cited by 208 · see citing works
Hashimoto, M., Hossain, M. S., Yamasaki, H., Yazawa, K., & Masumura, S. (1999) · Lipids · doi:10.1007/s11745-999-0481-6 · Cited by 189 · see citing works
Bhatt, D. L., Steg, P. G., Brinton, E. A., Jacobson, T. A., Miller, M., Tardif, J., Ketchum, S. B., Doyle, R. T., Murphy, S. A., Soni, P. N., et al. (2017) · Clinical Cardiology · doi:10.1002/clc.22692 · Cited by 183 · see citing works
Shaikh, S. R., Kinnun, J. J., Leng, X., Williams, J. A., & Wassall, S. R. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.04.020 · Cited by 179 · see citing works
Mason, R. P., Jacob, R. F., Shrivastava, S., Sherratt, S. C. R., & Chattopadhyay, A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.10.002 · Cited by 179 · see citing works
Self-citationWatanabe, T., Ando, K., Daidoji, H., Otaki, Y., Sugawara, S., Matsui, M., Ikeno, E., Hirono, O., Miyawaki, H., Yashiro, Y., et al. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.07.007 · Cited by 177 · see citing works
Borow, K. M., Nelson, J. R., & Mason, R. P. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.035 · Cited by 175 · see citing works
Self-citationTulenko, T. N., Chen, M., Mason, P. E., & Mason, R. P. (1998) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33861-x · Cited by 172 · see citing works
Self-citationDocosahexaenoic and eicosapentaenoic acids segregate differently between raft and nonraft domains
Williams, J. A., Batten, S. E., Harris, M., Rockett, B. D., Shaikh, S. R., Stillwell, W., & Wassall, S. R. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.06.016 · Cited by 168 · see citing works
Molecular organization of cholesterol in polyunsaturated membranes: microdomain formation
Brzustowicz, M. R., Cherezov, V., Caffrey, M., Stillwell, W., & Wassall, S. R. (2002) · Biophysical Journal · doi:10.1016/s0006-3495(02)75394-0 · Cited by 161 · see citing works
Shaikh, S. R. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.07.001 · Cited by 134 · see citing works
X-ray diffraction pattern of nerve myelin: a method for determining the phases
Moody, M. F. (1963) · Science · doi:10.1126/science.142.3596.1173 · Cited by 120 · see citing works
Effect of n-3 fatty acids on the expression of inflammatory genes in THP-1 macrophages
Allam‐Ndoul, B., Guénard, F., Barbier, O., & Vohl, M. (2016) · Lipids in Health and Disease · doi:10.1186/s12944-016-0241-4 · Cited by 117 · see citing works
Kučerka, N., Marquardt, D., Harroun, T. A., Nieh, M.-P., Wassall, S. R., de Jong, D. H., Schäfer, L. V., Marrink, S. J., & Katsaras, J. (2010) · Biochemistry · doi:10.1021/bi100891z · Cited by 112 · see citing works
Docosahexaenoic Acid Enhances Segregation of Lipids between Raft and Nonraft Domains: 2H-NMR Study
Soni, S. P., LoCascio, D. S., Liu, Y., Williams, J. A., Bittman, R., Stillwell, W., & Wassall, S. R. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.123612 · Cited by 89 · see citing works
Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Tsukuda, S., Yokohama, F., Sogo, M., Nishibe, T., Matsuo, N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.105 · Cited by 88 · see citing works
Mason, R. P., Walter, M. F., Day, C. A., & Jacob, R. F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513000200 · Cited by 86 · see citing works
Self-citationCholesterol alters the binding of Ca2+ channel blockers to the membrane lipid bilayer.
Mason, R. P., Moisey, D. M., & Shajenko, L. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08879-0 · Cited by 83 · see citing works
Self-citationPotential benefits of eicosapentaenoic acid on atherosclerotic plaques
Nelson, J. R., Wani, O. R., May, H. T., & Budoff, M. J. (2017) · Vascular Pharmacology · doi:10.1016/j.vph.2017.02.004 · Cited by 81 · see citing works
Mason, R. P., & Jacob, R. F. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.016 · Cited by 78 · see citing works
Self-citationRuocco, M. J., & Shipley, G. G. (1984) · Biophysical Journal · doi:10.1016/s0006-3495(84)84068-0 · Cited by 77 · see citing works
Mason, R. P., Sherratt, S. C. R., & Jacob, R. F. (2016) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000379 · Cited by 72 · see citing works
Self-citationMason, R. P., Gonye, G. E., Chester, D. W., & Herbette, L. G. (1989) · Biophysical Journal · doi:10.1016/s0006-3495(89)82875-9 · Cited by 56 · see citing works
Self-citationKučerka, N., Marquardt, D., Harroun, T. A., Nieh, M.-P., Wassall, S. R., & Katsaras, J. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907659u · Cited by 54 · see citing works
Doi, M., Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Nakayama, R., Takagi, W., Takeda, K., Hirohata, S., et al. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.08.055 · Cited by 51 · see citing works
Docosahexaenoyl Chains Isomerize on the Sub-Nanosecond Time Scale
Soubias, O., & Gawrisch, K. (2007) · Journal of the American Chemical Society · doi:10.1021/ja068856c · Cited by 48 · see citing works
X-Ray Diffraction Analysis of Membrane Structure Changes with Oxidative Stress
Mason, R. P., & Jacob, R. F. (2003) · Humana Press eBooks · doi:10.1385/1-59259-274-0:69 · Cited by 6 · see citing works
Self-citation
Flagged first, then by citations
3 of the 37 references couldn’t be matched to a known paper.
Research works printed but not linked: 1
- Mason, 1991, Use of X-ray and neutron diffraction to study small molecule interactions with model and native membranes, Comments Mol. Cell. Biophys., 7, 209
Cited by
Sorted by citations
Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Doyle, R. T., Juliano, R. A., Jiao, L., Granowitz, C., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1812792 · Cited by 3,317 · see citing works
Tocher, D., Betancor, M., Sprague, M., Olsen, R., & Napier, J. (2019) · Nutrients · doi:10.3390/nu11010089 · Cited by 615 · see citing works
Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid
Mason, R. P., Libby, P., & Bhatt, D. L. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313286 · Cited by 407 · see citing works
Self-citationSaini, R. K., Prasad, P., Sreedhar, R. V., Akhilender Naidu, K., Shang, X., & Keum, Y.-S. (2021) · Antioxidants · doi:10.3390/antiox10101627 · Cited by 337 · see citing works
Dietary fatty acids fine-tune Piezo1 mechanical response
Romero, L. O., Massey, A. E., Mata‐Daboin, A., Sierra-Valdez, F. J., Chauhan, S. C., Cordero-Morales, J. F., & Vásquez, V. (2019) · Nature Communications · doi:10.1038/s41467-019-09055-7 · Cited by 267 · see citing works
The eicosapentaenoic acid:arachidonic acid ratio and its clinical utility in cardiovascular disease
Nelson, J. R., & Raskin, S. (2019) · Postgraduate Medicine · doi:10.1080/00325481.2019.1607414 · Cited by 153 · see citing works
Preston Mason, R. (2019) · Current Atherosclerosis Reports · doi:10.1007/s11883-019-0762-1 · Cited by 129 · see citing works
Self-citationDocosahexaenoic acid, 22:6n‐3: Its roles in the structure and function of the brain
Mallick, R., Basak, S., & Duttaroy, A. K. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.10.004 · Cited by 113 · see citing works
EPA and DHA containing phospholipids have contrasting effects on membrane structure
Sherratt, S. C. R., Juliano, R. A., Copland, C., Bhatt, D. L., Libby, P., & Mason, R. P. (2021) · Journal of Lipid Research · doi:10.1016/j.jlr.2021.100106 · Cited by 92 · see citing works
Self-citationGlencross, B. D., Bachis, E., Betancor, M. B., Calder, P., Liland, N., Newton, R., & Ruyter, B. (2025) · Reviews in Fisheries Science & Aquaculture · doi:10.1080/23308249.2024.2388563 · Cited by 89 · see citing works
Mason, R. P., Dawoud, H., Jacob, R. F., Sherratt, S. C. R., & Maliñski, T. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.118 · Cited by 84 · see citing works
Self-citationEPA and DHA differentially modulate membrane elasticity in the presence of cholesterol
Jacobs, M. L., Faizi, H. A., Peruzzi, J. A., Vlahovska, P. M., & Kamat, N. P. (2021) · Biophysical Journal · doi:10.1016/j.bpj.2021.04.009 · Cited by 72 · see citing works
Sherratt, S. C. R., Juliano, R. A., & Mason, R. P. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183254 · Cited by 67 · see citing works
Self-citationDo patients benefit from omega-3 fatty acids?
Sherratt, S. C. R., Mason, R. P., Libby, P., Steg, P. G., & Bhatt, D. L. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad188 · Cited by 71 · see citing works
Self-citationCardiovascular Impact of Nutritional Supplementation With Omega-3 Fatty Acids
Weinberg, R. L., Brook, R. D., Rubenfire, M., & Eagle, K. A. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.11.060 · Cited by 63 · see citing works
New Therapies for Lowering Triglyceride-Rich Lipoproteins
Rosenson, R. S., Shaik, A., & Song, W. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.08.051 · Cited by 67 · see citing works
Do Eicosapentaenoic Acid and Docosahexaenoic Acid Have the Potential to Compete against Each Other?
Pal, A., Metherel, A. H., Fiabane, L., Buddenbaum, N., Bazinet, R. P., & Shaikh, S. R. (2020) · Nutrients · doi:10.3390/nu12123718 · Cited by 62 · see citing works
Dietary and Pharmacological Fatty Acids and Cardiovascular Health
Wu, H., Xu, L., & Ballantyne, C. M. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz174 · Cited by 59 · see citing works
Verma, S., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Dhingra, N. K., Ketchum, S. B., Juliano, R. A., Jiao, L., et al. (2021) · Circulation · doi:10.1161/circulationaha.121.056290 · Cited by 60 · see citing works
Self-citationPeterson, B. E., Bhatt, D. L., Steg, P. G., Miller, M., Brinton, E. A., Jacobson, T. A., Ketchum, S. B., Juliano, R. A., Jiao, L., Doyle, R. T., et al. (2021) · Circulation · doi:10.1161/circulationaha.120.050276 · Cited by 57 · see citing works
Model architectures for bacterial membranes
Carey, A. B., Ashenden, A. J., & Köper, I. (2022) · Biophysical Reviews · doi:10.1007/s12551-021-00913-7 · Cited by 57 · see citing works
Sherratt, S. C. R., Dawoud, H., Bhatt, D. L., Maliñski, T., & Mason, R. P. (2021) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2021.102337 · Cited by 51 · see citing works
Self-citationVeltman, M., Sanctis, J. B. D., Stolarczyk, M., Klymiuk, N., Bähr, A., Brouwer, R. W. W., Oole, E., Shah, J., Oždian, T., Liao, J., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.619442 · Cited by 46 · see citing works
O’Connell, T. D., Mason, R. P., Budoff, M. J., Návar, A. M., & Shearer, G. C. (2020) · European Heart Journal Supplements · doi:10.1093/eurheartj/suaa115 · Cited by 44 · see citing works
Self-citationYang, T., Yi, J., He, Y., Zhang, J., Li, X., Ke, S., Xia, L., & Liu, L. (2022) · Nutrients · doi:10.3390/nu14173608 · Cited by 42 · see citing works
Chapman, M. J., & Mason, R. P. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108237 · Cited by 41 · see citing works
Self-citationSherratt, S. C. R., Libby, P., Bhatt, D. L., & Mason, R. P. (2022) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2022.102450 · Cited by 45 · see citing works
Self-citationBashir, B., Schofield, J., Downie, P., France, M., Ashcroft, D. M., Wright, A. K., Romeo, S., Gouni-Berthold, I., Maan, A., Durrington, P. N., et al. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1389106 · Cited by 40 · see citing works
Yasuzawa, T., Nakamura, T., Ueshima, S., & Mima, A. (2021) · Journal of Diabetes Research · doi:10.1155/2021/2182225 · Cited by 39 · see citing works
Omega-3 fatty acids for cardiovascular event lowering
Kaur, G., Mason, R. P., Steg, P. G., & Bhatt, D. L. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae003 · Cited by 40 · see citing works
Self-citationXu, X., Zhao, W., Ye, Y., Cui, W., Dong, L., Yao, Y., Li, K., Han, J., & Liu, W. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02817 · Cited by 35 · see citing works
Omega-3 Fatty Acids in Arterial Hypertension: Is There Any Good News?
Brosolo, G., Porto, A. D., Marcante, S., Picci, A., Capilupi, F., Capilupi, P., Bertin, N., Vivarelli, C., Bulfone, L., Vacca, A., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119520 · Cited by 42 · see citing works
Cardiovascular effects of omega-3 fatty acids: Hope or hype?
Jo, S., Han, S. H., Kim, S., Eckel, R. H., & Koh, K. K. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.02.014 · Cited by 31 · see citing works
Polyunsaturated fatty acids and sepsis
Das, U. N. (2019) · Nutrition · doi:10.1016/j.nut.2019.02.016 · Cited by 30 · see citing works
Sprague, M., Gong, X., Betancor, M. B., Olsen, R. E., Torrissen, O. J., Glencross, B. D., & Tocher, D. R. (2019) · British Journal Of Nutrition · doi:10.1017/s0007114519001946 · Cited by 30 · see citing works
Omega-3 and cardiovascular prevention – Is this still a choice?
Ruscica, M., Sirtori, C. R., Carugo, S., Calder, P. C., & Corsini, A. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106342 · Cited by 28 · see citing works
Yokoi, K., Yanagimoto, K., & Hayamizu, K. (2022) · Nutrients · doi:10.3390/nu14194136 · Cited by 27 · see citing works
The effects of molecular and nanoscopic additives on phospholipid membranes
Kumarage, T., Morris, N. B., & Ashkar, R. (2023) · Frontiers in Physics · doi:10.3389/fphy.2023.1251146 · Cited by 26 · see citing works
Cardiovascular Risk Reduction with Icosapent Ethyl
(2019) · New England Journal of Medicine · doi:10.1056/nejmc1902165 · Cited by 24 · see citing works
Omega-3 Fatty Acids and Arrhythmias
Marcus, M. D., & Link, M. S. (2024) · Circulation · doi:10.1161/circulationaha.123.065769 · Cited by 24 · see citing works
Bhatt, R. D., Libby, P., Verma, S., Mason, R. P., & Bhatt, D. L. (2021) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2021.08.003 · Cited by 22 · see citing works
Self-citationde Sá, R. D. C. D. C., Simão, J. D. J., da Silva, V. S., Farias, T. M., Cruz, M. M., Antraco, V. J., Armelin‐Correa, L., & Alonso‐Vale, M. I. C. (2021) · Nutrients · doi:10.3390/nu13030754 · Cited by 21 · see citing works
Structural determinants of acid-sensing ion channel potentiation by single chain lipids
Klipp, R. C., & Bankston, J. R. (2022) · The Journal of General Physiology · doi:10.1085/jgp.202213156 · Cited by 19 · see citing works
Dinu, M., Sofi, F., Lotti, S., Colombini, B., Mattioli, A. V., Catapano, A. L., Casula, M., Baragetti, A., Wong, N. D., Steg, P. G., et al. (2024) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwae184 · Cited by 17 · see citing works
Sherratt, S. C. R., Libby, P., Dawoud, H., Bhatt, D. L., Maliñski, T., & Mason, R. P. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114629 · Cited by 17 · see citing works
Self-citationPedroni, V. I., Sierra, M. B., Alarcón, L. M., Verde, A. R., Appignanesi, G. A., & Morini, M. A. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183584 · Cited by 17 · see citing works
Deckelbaum, R. J., & Calder, P. C. (2020) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000632 · Cited by 17 · see citing works
Chang, W.-C., So, J., & Lamon‐Fava, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-95590-7 · Cited by 16 · see citing works
Brosolo, G., Porto, A. D., Marcante, S., Capilupi, F., Bertin, N., Vivarelli, C., Bulfone, L., Vacca, A., Catena, C., & Sechi, L. A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177107 · Cited by 15 · see citing works
Raman study of temperature-induced hydrocarbon chain disorder in saturated phosphatidylcholines
Zaytseva, Y. V., Adichtchev, S. V., & Surovtsev, N. V. (2020) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2020.104926 · Cited by 15 · see citing works
Dupertuis, Y. M., Boulens, N., Angibaud, E., Briod, A., Viglione, A., Allémann, É., Delié, F., & Pichard, C. (2021) · AAPS PharmSciTech · doi:10.1208/s12249-020-01897-5 · Cited by 15 · see citing works
Foley, S., Miller, E., Braziel, S., & Lee, S. (2020) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2020.183365 · Cited by 15 · see citing works
Strategies for chronic coronary disease: A brief guide for clinicians
Krittanawong, C., Khawaja, M., Virk, H. U. H., Escobar, J., Khalid, U., Birnbaum, Y., Lavie, C. J., Sharma, S. K., Jneid, H. M., Rao, S. V., et al. (2024) · npj Cardiovascular Health · doi:10.1038/s44325-024-00006-w · Cited by 17 · see citing works
Zhang, W., Gan, D., Huo, S., & Chen, P. (2024) · Frontiers in Nutrition · doi:10.3389/fnut.2024.1490953 · Cited by 14 · see citing works
Iqbal, T., & Miller, M. J. (2021) · Current Cardiology Reports · doi:10.1007/s11886-021-01527-x · Cited by 14 · see citing works
Order vs. Disorder: Cholesterol and Omega-3 Phospholipids Determine Biomembrane Organization
Santis, A. D., Scoppola, E., Ottaviani, M. F., Koutsioubas, A. G., Barnsley, L. C., Paduano, L., D’Errico, G., & Krauss, I. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105322 · Cited by 14 · see citing works
Gonzalez, D. E., Dickerson, B. L., Roberts, B. M., Kurtz, J. A., Waldman, H. S., Gonzalez, A. M., McAllister, M. J., Heileson, J. L., Bloomer, R. J., Arent, S. M., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2629828 · Cited by 15 · see citing works
Shimizu, K., Kuramochi, Y., & Hayamizu, K. (2024) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.24-36 · Cited by 13 · see citing works
Kapoor, K., Alfaddagh, A., Stone, N. J., & Blumenthal, R. S. (2021) · Journal of clinical lipidology · doi:10.1016/j.jacl.2021.06.004 · Cited by 13 · see citing works
Oxygenated lipid signaling in tumor-associated macrophages—focus on colon cancer
Colby, J. K., Jaoude, J. C., Liu, F., & Shureiqi, I. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9743-z · Cited by 12 · see citing works
Bazarbashi, N., & Miller, M. J. (2020) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2020.1749596 · Cited by 11 · see citing works
Ogawa, T., Hirose, K., Yusuf, Y., Kawamoto, J., & Kurihara, T. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01104 · Cited by 11 · see citing works
Zhu, J., Li, S., Chen, W., Xu, X., Wang, X., Wang, X.-W., Han, J., Jouhet, J., Amato, A., Maréchal, É., et al. (2024) · PLANT PHYSIOLOGY · doi:10.1093/plphys/kiae297 · Cited by 10 · see citing works
Mi-mba, M.-F. O. M., Lebbadi, M., Alata, W., Julien, C., Émond, V., Tremblay, C., Fortin, S., Barrow, C. J., Bilodeau, J., & Calon, F. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100682 · Cited by 10 · see citing works
Joardar, A., & Chakraborty, H. (2023) · Langmuir · doi:10.1021/acs.langmuir.3c00119 · Cited by 10 · see citing works
Zhang, D., Gong, C., Wang, J., Xing, D., Zhao, L., Li, D., & Zhang, X. (2021) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.1c01965 · Cited by 9 · see citing works
Verde, A. R., Sierra, M. B., Alarcón, L. M., Pedroni, V. I., Appignanesi, G. A., & Morini, M. A. (2018) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2018.10.003 · Cited by 8 · see citing works
Lachaine, J., Charron, J.-N., Gregoire, J. C., Hegele, R. A., & Leiter, L. A. (2023) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s377935 · Cited by 7 · see citing works
Khabir, Z., Abdelhafez, A., Camponovo, F. F., Joyce, P., & Garcia‐Bennett, A. E. (2026) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2026.2615693 · Cited by 8 · see citing works
Safaei, P., Bayat, G., & Mohajer, A. (2024) · Systematic Reviews · doi:10.1186/s13643-023-02426-8 · Cited by 7 · see citing works
Zhang, Z., Lin, Y., Lian, M., Li, Y., Chen, J.-F., Ma, X., Guo, D., Yang, G., & Sun, X. (2025) · Algal Research · doi:10.1016/j.algal.2025.104072 · Cited by 6 · see citing works
Nutrients and Nutraceuticals in Aging
Hodjat, M., Khalid, M., Asghari, M., Atri, S., Rahimifard, M., Nejad, S. M., & Baeeri, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-3552-9_5 · Cited by 6 · see citing works
Urinary and Plasma Antioxidants in Behavioral Symptoms of Individuals With Autism Spectrum Disorder
Imataka, G., Yui, K., Shiko, Y., Kawasaki, Y., Sasaki, H., Shiroki, R., & Yoshihara, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.684445 · Cited by 6 · see citing works
Santis, A. D., Vitiello, G., Appavou, M., Scoppola, E., Fragneto, G., Barnsley, L. C., Clifton, L. A., Ottaviani, M. F., Paduano, L., Krauss, I. R., et al. (2020) · Soft Matter · doi:10.1039/d0sm01549k · Cited by 6 · see citing works
Riedel, S., Abel, S., Burger, H. ‐., Swanevelder, S. A., & Gelderblom, W. C. A. (2024) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2024.184310 · Cited by 5 · see citing works
Ito, N., Hishikari, K., Abe, F., Kanno, Y., Iiya, M., Murai, T., Hikita, H., Takahashi, A., Yonetsu, T., & Sasano, T. (2020) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2020.08.030 · Cited by 5 · see citing works
On the Structure and Flip-flop of Free Docosahexaenoic Acid in a Model Human Brain Membrane
Yee, S. M., & Lorenz, C. D. (2021) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.1c03929 · Cited by 5 · see citing works
Orringer, C. E. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.04.009 · Cited by 4 · see citing works
The role of icosapent ethyl in cardiovascular risk reduction
Goldenberg, R., CHENG, A. Y. Y., Gilbert, J. D., Lonn, E., Pedersen, S. D., & Verma, S. (2021) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000873 · Cited by 3 · see citing works
Khoukaz, H. B., & Fay, W. P. (2021) · PubMed Central · Cited by 3 · see citing works
Powell, J. A., & Burgess, S. C. (2024) · Journal of Experimental Biology · doi:10.1242/jeb.247776 · Cited by 2 · see citing works
Sherratt, S. C. R., Libby, P., Bhatt, D. L., & Mason, R. P. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-41192-2_17 · Cited by 1 · see citing works
Self-citationImpact of fish oil on epigenetic regulation in perirenal adipose tissue of obese mice
Plata, V. T. G., Simão, J. D. J., Bispo, A. F. D. S., Alonso‐Vale, M. I. C., & Armelin‐Correa, L. (2025) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2025.03.006 · Cited by 1 · see citing works
Okagu, I. U., Aguchem, R. N., Ogbu, C. P., & Omeje, A. (2026) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2026.100510 · Cited by 1 · see citing works
Enrichment of eicosapentaenoic acid and synthesis of phytosteryl esters by one-step enzyme reaction
Kang, J., Lee, C., Kim, B. H., & Kim, I.-H. (2026) · Enzyme and Microbial Technology · doi:10.1016/j.enzmictec.2026.110905 · Cited by 1 · see citing works
Cardioprotective mechanisms of cytochrome P450 derived oxylipins from ω-3 and ω-6 PUFAs
Cho, C., Aliwarga, T., Wiley, A. M., & Totah, R. A. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.02.001 · Cited by 1 · see citing works
Sergent, O., Podechard, N., & Lagadic‐Gossmann, D. (2018) · Cahiers de Nutrition et de Diététique · doi:10.1016/j.cnd.2018.11.001
Nakagawa, H. (2020) · AIP Advances · doi:10.1063/1.5130189
Icosapent Ethyl for the Prevention of Cardiovascular Events
Lloyd, J. (2019) · EMJ Cardiology · doi:10.33590/emjcardiol/10311840
Zhu, J., Li, S., Chen, W., Xu, X., Wang, X.-P., Wang, X., Han, J., Jouhet, J., Amato, A., Maréchal, É., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.19.590303
Evidencia en la prevención cardiovascular con icosapento de etilo
Díaz-Díaz, J. L. (2025) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2025.500818
Evidence on cardiovascular prevention with icosapent ethyl
Díaz-Díaz, J. L. (2025) · Clínica e Investigación en Arteriosclerosis (English Edition) · doi:10.1016/j.artere.2025.500818
Dietary and nutritional supplementation strategies for table tennis athletes: a mini-review
Wang, Z., Shen, L., & Gao, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1849900
Kang, J., Lee, C., Lee, J., Kim, B. H., Kim, H., & Kim, I.-H. (2026) · Journal of the American Oil Chemists Society · doi:10.1002/aocs.70148
DHA-dominant Omega-3 compositions enhance PSD-95 organization and glutamatergic protein expression
Medina, G., Baird, S. D., Rodriguez-Alcocer, L. A., & MacKenzie, A. (2026) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2026.1947075
- Authors
- Sherratt, S. C. R., & Mason, R. P.
- Affiliations
- Brigham and Women's Hospital (US)
- Corresponding author
- Mason, R. Preston
- Venue
- Chemistry and Physics of Lipids
- Publisher
- Elsevier BV
- Published
- 2018-05
- Volume
- 212
- Pages
- 73-79
- ISSN
- 0009-3084 (ISSN-L)
- OpenAlex
- W2790714701
- Cited by
- 95
- References
- 37
- Citations by year
- 2026: 7 · 2025: 4 · 2024: 15 · 2023: 8 · 2022: 8 · 2021: 23 · 2020: 14 · 2019: 11 · 2018: 5
- FWCI
- 4.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Chemistry and Physics of Lipids (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Lipid Membrane Structure and Behavior
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- eicosapentaenoic acid, docosahexaenoic acid, omega-3 fatty acids, membrane structure, lipid orientation, electron density profile, trans-gauche isomerization, membrane fluidity, lipid oxidation, signal transduction
- MeSH terms
- Cholesterol, Docosahexaenoic Acids, Isomerism, Membrane Fluidity, Phosphatidylcholines, Temperature, X-Ray Diffraction, Eicosapentaenoic Acid, Unilamellar Liposomes, Scattering, Small Angle
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review